Pretreatment with adenosine and adenosine A1 receptor agonist protects againts intestinal ischemia-reperfusion injury in rat

World Journal of Gastroenterology

Volumn 13, Issue 4, 2007, Pages 538-547

  Ozacmak, V Haktan ^a   Sayan, Hale ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Adenosine; Adenosine A1 receptor; Intestinal ischemia; Pharmacological preconditioning

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; CARBACHOL; GLUTATHIONE; MALONALDEHYDE; MYELOPEROXIDASE; POTASSIUM CHLORIDE; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ILEUM; INTESTINE ISCHEMIA; MALE; MUSCLE CONTRACTION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; RAT; REPERFUSION INJURY; STOMACH PROTECTION; WISTAR RAT;

EID: 33846809053     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i4.538     Document Type: Article

References (55)

1. Mallick IH, Yang W, Winslet MC, Seifalian AM. Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci 2004; 49: 1359-1377
2. Lodato RF, Khan AR, Zembowicz MJ, Weisbrodt NW, Pressley TA, Li YF, Lodato JA, Zembowicz A, Moody FG. Roles of IL-1 and TNF in the decreased ileal muscle contractility induced by lipopolysaccharide. Am J Physiol 1999; 276: G1356-G1362
3. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000; 190: 255-266
4. Arumugam TV, Shiels IA, Woodruff TM, Reid RC, Fairlie DP, Taylor SM. Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine. J Surg Res 2002; 103: 260-267
5. Bielefeldt K, Conklin JL. Intestinal motility during hypoxia, and reoxygenation in vitro. Dig Dis Sci 1997; 42: 878-884
6. Khanna A, Rossman JE, Fung HL, Caty MG. Attenuated nitric oxide synthase activity and protein expression accompany intestinal ischemia/ reperfusion injury in rats. Biochem Biophys Res Commun 2000; 269: 160-164
7. Poussios D, Andreadou I, Papalois A, Rekka E, Gavalakis N, Aroni K, Kourounakis PN, Fotiadis C, Sechas MN. Protective effect of a novel antioxidant non-steroidal anti-inflammatory agent (compound IA) on intestinal viability after acute mesenteric ischemia and reperfusion. Eur J Pharmacol 2003; 465: 275-280
8. Takahashi A, Tomomasa T, Kaneko H, Watanabe T, Tabata M, Morikawa H, Tsuchida. Y, Kuwano H. Intestinal motility in an in vivo rat model of intestinal ischemia-reperfusion with special reference to the effects of nitric oxide on the motility changes. J Pediatr Gastroenterol Nutr 2001; 33: 283-288
9. Ozacmak VH, Sayan H, Arslan SO, Altaner S, Aktas RG. Protective effect of melatonin on contractile activity and oxidative injury induced by ischemia and reperfusion of rat ileum. Life Sci 2005; 76: 1575-1588
10. Hassoun HT, Weisbrodt NW, Mercer DW, Kozar RA, Moody FG, Moore FA. Inducible nitric oxide synthase mediates gut ischemia/ reperfusion-induced ileus only after severe insults. J Surg Res 2001; 97: 150-154
11. Baxter GF. Role of adenosine in delayed preconditioning of myocardium. Cardiovasc Res 2002; 55: 483-494
12. Mubagwa K, Flameng W. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc Res 2001; 52: 25-39
13. Kadowaki M, Tokita K, Nagakura Y, Takeda. M, Hanaoka K, Tomoi M. Adenosine A1 receptor blockade reverses dysmotility induced by ischemia-reperfusion in rat colon. Eur J Pharmacol 2000; 409: 319-323
14. Nicholls J, Hourani SM. Characterization of adenosine receptors on rat ileum, ileal longitudinal muscle and muscularis mucosae. Eur J Pharmacol 1997; 338: 143-150
15. Dana A, Jonassen AK, Yamashita N, Yellon DM. Adenosine A(1) receptor activation induces delayed preconditioning in rats mediated by manganese superoxide dismutase. Circulation 2000; 101: 2841-2848
16. Mozzicato S, Joshi BV, Jacobson KA, Liang BT. Role of direct RhoA-phospholipase D1 interaction in mediating adenosine-induced protection from cardiac ischemia. FASEB J 2004; 18: 406-408
17. De Jonge R, Out M, Maas WJ, De Jong JW. Preconditioning of rat hearts by adenosine A1 or A3 receptor activation. Eur J Pharmacol 2002; 441: 165-172
18. Kristo G, Yoshimura Y, Keith BJ, Stevens RM, Jahania SA, Mentzer RM Jr, Lasley RD. Adenosine A1/A2a receptor agonist AMP-579 induces acute and delayed preconditioning against in vivo myocardial stunning. Am J Physiol Heart Circ Physiol 2004; 287: H2746-H2753
19. Headrick JP, Hack B, Ashton KJ. Acute adenosinergic cardioprotection in ischemic-reperfused hearts. Am J Physiol Heart Circ Physiol 2003; 285: H1797-H1818
20. Solenkova NV, Solodushko V, Cohen MV, Downey JM. Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt. Am J Physiol Heart Circ Physiol 2006; 290: H441-H449
21. Maddock HL, Mocanu MM, Yellon DM. Adenosine A(3) receptor activation protects the myocardium from reperfusion/reoxygenation injury. Am J Physiol Heart Circ Physiol 2002; 283: H1307-H1313
22. Lee HT, Gallos G, Nasr SH, Emala CW. A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 2004; 15: 102-111
23. Randhawa MP, Lasley RD, Mentzer RM Jr. Salutary effects of exogenous adenosine administration on in vivo myocardial stunning. J Thorac Cardiovasc Surg 1995; 110: 63-74
24. Sekili S, Jeroudi MO, Tang XL, Zughaib M, Sun JZ, Bolli R. Effect of adenosine on myocardial 'stunning' in the dog. Circ Res 1995; 76: 82-94
25. Yoshimura Y, Kristo G, Keith BJ, Jahania SA, Mentzer RM Jr, Lasley RD. The p38 MAPK inhibitor SB203580 blocks adenosine A(1) receptor-induced attenuation of in vivo myocardial stunning. Cardiovasc Drugs and Ther 2004; 18: 433-440
26. Sugino H, Shimada H, Tsuchimoto K. Role of adenosine in renal protection induced by a brief episode of ischemic preconditioning in rats. Jpn J Pharmacol 2001; 87: 134-142
27. Lee HT, Xu H, Nasr SH, Schnermann J, Emala CW. A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion. Am J Physiol Renal Physiol 2004; 286: F298-F306
28. Nakamura M, Nakakimura K, Matsumoto M, Sakabe T. Rapid tolerance to focal cerebral ischemia in rats is attenuated by adenosine A1 receptor antagonist. J Cereb Blood Flow Metab 2002; 22: 161-170
29. Hiraide T, Katsura K, Muramatsu H, Asano G, Katayama Y. Adenosine receptor antagonists cancelled the ischemic tolerance phenomenon in gerbil. Brain Res 2001; 910: 94-98
30. Kudo M, Wang Y, Xu M, Ayub A, Ashraf M. Adenosine A(1) receptor mediates late preconditioning via activation of PKC-delta signaling pathway. Am J Physiol Heart Circ Physiol 2002; 283: H296-H301
31. Zhao X, Alexander JS, Zhang S, Zhu Y, Sieber NJ, Aw TY, Carden DL. Redox regulation of endothelial barrier integrity. Am J Physiol Lung Cell Mol Physiol 2001; 281: L879-L886
32. Reid EA, Kristo G, Yoshimura Y, Ballard-Croft C, Keith BJ, Mentzer RM Jr, Lasley RD. In vivo adenosine receptor preconditioning reduces myocardial infarct size via subcellular ERK signaling. Am J Physiol Heart Circ Physiol 2005; 288: H2253-H2259
33. Ballard-Croft C, Kristo G, Yoshimura Y, Reid E, Keith BJ, Mentzer RM Jr, Lasley RD. Acute adenosine preconditioning is mediated by p38 MAPK activation in discrete subcellular compartments. Am J Physiol Heart Circ Physiol 2005; 288: H1359-1366
34. Ramkumar V, Hallam DM, Nie Z. Adenosine, oxidative stress and cytoprotection. Jpn J Pharmacol 2001; 86: 265-274
35. Ishida T, Yarimizu K, Gute DC, Korthuis RJ. Mechanisms of ischemic preconditioning. Shock 1997; 8: 86-94
36. Mallick IH, Yang W, Winslet MC, Seifalian AM. Ischaemic preconditioning improves microvascular perfusion and oxygenation following reperfusion injury of the intestine. Br J Surg 2005; 92: 1169-1176
37. Unal S, Demirkan F, Arslan E, Cin I, Cinel L, Eskandari G, Cinel I. Comparison of ischemic and chemical preconditioning in jejunal. flaps in the rat. Plast Reconstr Surg 2003; 112: 1024-1031
38. Davis JM, Gute DC, Jones S, Krsmanovic A, Korthuis RJ. Ischemic preconditioning prevents postischemic P-selectin expression in the rat small intestine. Am J Physiol Heart Circ Physiol 1999; 277: H2476-H2481
39. Vlasov TD, Smirnov DA, Nutfullina GM. Preconditioning of the small intestine to ischemia in rats. Neurosci Behav Physiol 2002; 32: 449-453
40. Sola A, De Oca J, Gonzalez R, Prats N, Rosello-Catafau J, Gelpi E, Jaurrieta E, Hotter G. Protective effect of ischemic preconditioning on cold preservation and reperfusion injury associated with rat intestinal transplantation. Ann Surg 2001; 234: 98-106
41. Hotter G, Closa D, Prados M, Fernandez-Cruz L, Prats N, Gelpi E, Rosello-Catafau J. Intestinal preconditioning is mediated by a transient increase in nitric oxide. Biochem Biophys Res Commun 1996; 222: 27-32
42. Yang SP, Hao YB, Wu YX, Dun W, Shen LH, Zhang Y. Ischemic preconditioning mediated by activation of KATP channels in rat small intestine. Zhongguo Yao Li Xue Bao 1999; 20: 341-344
43. Zhang Y, Wu YX, Hao YB, Dun Y, Yang SP. Role of endogenous opioid peptides in protection of ischemic preconditioning in rat small intestine. Life Sci 2001; 68: 1013-1019
44. Boucher M, Pesant S, Falcao S, de Montigny C, Schampaert E, Cardinal R, Rousseau G. Post-ischemic cardioprotection by A2A adenosine receptors: dependent of phosphatidylinositol 3-kinase pathway. J Cardiovasc Pharmacol 2004; 43: 416-422
45. Boucher M, Wann BP, Kaloustian S, Masse R, Schampaert E, Cardinal R, Rousseau G. Sustained cardioprotection afforded by A2A adenosine receptor stimulation after 72 hours of myocardial reperfusion. J Cardiovasc Pharmacol 2005; 45: 439-446
46. Kaya TT, Koyluoglu G, Soydan AS, Arpacik M, Karadas B. Effects of nimesulide and pentoxifylline on decreased contractile responses in rat ileum with peritonitis. Eur J Pharmacol 2002; 442: 147-153
47. Casini A, Ferrali M, Pompella A, Maellaro E, Comporti M. Lipid peroxidation and cellular damage in extrahepatic tissues of bromobenzene-intoxicated mice. Am J Pathol 1986; 123: 520-531
48. Aykac G, Uysal M, Yalcin AS, Kocak-Toker N, Sivas A, Oz H. The effect of chronic ethanol ingestion on hepatic lipid peroxide, glutathione, glutathione peroxidase and glutathione transferase in rats. Toxicology 1985; 36: 71-76
49. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78: 206-209
50. Ferrer JV, Ariceta J, Guerrero D, Gomis T, Larrea MM, Balen E, Lera JM. Allopurinol and N-acetylcysteine avoid 60% of intestinal necrosis in an ischemia-reperfusion experimental model. Transplant Proc 1998; 30: 2672
51. Jacob T, Ascher E, Hingorani A, Kallakuri S. Glycine prevents the induction of apoptosis attributed to mesenteric ischemia/reperfusion injury in a rat model. Surgery 2003; 134: 457-466
52. Aban N, Cinel L, Tamer L, Aktas A, Aban M. Ischemic preconditioning reduces caspase-related intestinal apoptosis. Surg Today 2005; 35: 228-234
53. Lee HT, Emala CW. Adenosine attenuates oxidant injury in human proximal tubular cells via A(1) and A(2a) adenosine receptors. Am J Physiol Renal Physiol 2002; 282: F844-F852
54. Narayan P, Mentzer RM Jr, Lasley RD. Adenosine A1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes. J Mol Cell Cardiol 2001; 33: 129-221
55. Thomas GP, Sims SM, Cook MA, Karmazyn M. Hydrogen peroxide-induced stimulation of L-type calcium current in guinea pig ventricular myocytes and its inhibition by adenosine A1 receptor activation. J Pharmacol Exp Ther 1998; 286: 1208-1214